(Q34993070)

5 August 2017

title

HIV-1 drug resistance in recently HIV-infected pregnant mother's naïve to antiretroviral therapy in Dodoma urban, Tanzania (English)

1 reference

5 August 2017

0 references

15

1 reference

5 August 2017

Francesco Vairo

1

0 references

Pasquale De Nardo

Pasquale De Nardo

10

0 references

Federica Forbici

Federica Forbici

7

0 references

Alessandra Amendola

Alessandra Amendola

Maria Rosaria Capobianchi

8

0 references

Maria Rosaria Capobianchi

14

0 references

Lavinia Fabeni

Lavinia Fabeni

9

0 references

Emanuele Nicastri

Emanuele Nicastri

2

0 references

Carlo Federico Perno

11

Carlo Federico Perno

1 reference

5 August 2017

3

Giuseppina Liuzzi

1 reference

5 August 2017

Zainab Chaula

4

1 reference

5 August 2017

Boniface Nguhuni

5

1 reference

5 August 2017

Nazario Bevilacqua

6

1 reference

5 August 2017

Angela Cannas

12

1 reference

5 August 2017

Calistus Sakhoo

13

1 reference

5 August 2017

AMANI Study Group

16

1 reference

5 August 2017

publication date

21 September 2013

1 reference

5 August 2017

published in

BMC Infectious Diseases

1 reference

5 August 2017

volume

13

1 reference

5 August 2017

page(s)

439

1 reference

Creative Commons Attribution 2.0 Generic

5 August 2017

copyright license

start time

21 September 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-13-439

0 references

cites work

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

Clinical and immunogenetic correlates of abacavir hypersensitivity

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-439

Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-439

Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: resistance to AR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-439

Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-439

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-439

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-439

Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-439

Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-439

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849050

K65R development among subtype C HIV-1-infected patients in tenofovir DF clinical trials

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24053581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-13-439

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference